Cargando…

“Drug‐Carrier” Synergy Therapy for Amyloid‐β Clearance and Inhibition of Tau Phosphorylation via Biomimetic Lipid Nanocomposite Assembly

Amyloid‐β (Aβ) toxicity is considered to be companioned by Tau phosphorylation in Alzheimer's disease (AD). The clinical AD therapy is usually subjected to low blood‐brain barrier (BBB) penetration and complex interaction mechanisms between Aβ and phosphorylated Tau. A “Drug‐Carrier” synergy th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Han, Guochen, Bai, Kaiwen, Yang, Xiaoyu, Sun, Chenhua, Ji, Yi, Zhou, Jianping, Zhang, Huaqing, Ding, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9108666/ https://www.ncbi.nlm.nih.gov/pubmed/35307993 http://dx.doi.org/10.1002/advs.202106072

Ejemplares similares

Amyloid-β and hyperphosphorylated tau synergy drives metabolic decline in preclinical Alzheimer's disease
por: Pascoal, T A, et al.
Publicado: (2017)

Regional correlation of biochemical measures of amyloid and tau phosphorylation in the brain
por: Horie, Kanta, et al.
Publicado: (2020)

Disease‐Associated Tau Phosphorylation Hinders Tubulin Assembly within Tau Condensates
por: Savastano, Adriana, et al.
Publicado: (2020)

Amyloid-beta and phosphorylated tau in post-mortem Alzheimer’s disease retinas
por: den Haan, Jurre, et al.
Publicado: (2018)

Plasma phosphorylated-tau181 as a predictive biomarker for Alzheimer’s amyloid, tau and FDG PET status
por: Shen, Xue-Ning, et al.
Publicado: (2021)

Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission Tomography
por: Therriault, Joseph, et al.
Publicado: (2022)

Agomelatine Prevents Amyloid Plaque Deposition, Tau Phosphorylation, and Neuroinflammation in APP/PS1 Mice
por: Yang, Xiao-bo, et al.
Publicado: (2022)

Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer’s Disease
por: Reddy, P. Hemachandra, et al.
Publicado: (2019)

Assessment of tau phosphorylation and β‐amyloid pathology in human drug‐resistant epilepsy
por: Aroor, Alisha, et al.
Publicado: (2023)

CSF tau phosphorylation occupancies at T217 and T205 represent improved biomarkers of amyloid and tau pathology in Alzheimer’s disease
por: Barthélemy, Nicolas R., et al.
Publicado: (2023)

Potential synergy between tau aggregation inhibitors and tau chaperone modulators
por: Blair, Laura J, et al.
Publicado: (2013)

Repetitive Biomimetic Self-healing of Ca(2+)-Induced Nanocomposite Protein Hydrogels
por: Chen, Jun, et al.
Publicado: (2016)

Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid β-protein and phosphorylated tau
por: Du, Xiaoxi, et al.
Publicado: (2022)

MAPT R406W increases tau T217 phosphorylation in absence of amyloid pathology
por: Sato, Chihiro, et al.
Publicado: (2021)

Plasma amyloid-beta oligomer and phosphorylated tau: diagnostic tools for progressive Alzheimer’s disease
por: An, Seong Soo A., et al.
Publicado: (2023)

Virus-Incorporated Biomimetic Nanocomposites for Tissue Regeneration
por: Raja, Iruthayapandi Selestin, et al.
Publicado: (2019)

Biomimetic Reversible Heat-Stiffening Polymer Nanocomposites
por: Cudjoe, Elvis, et al.
Publicado: (2017)

Soluble P‐tau217 reflects amyloid and tau pathology and mediates the association of amyloid with tau
por: Mattsson‐Carlgren, Niklas, et al.
Publicado: (2021)

Pseudo-acetylation of multiple sites on human Tau proteins alters Tau phosphorylation and microtubule binding, and ameliorates amyloid beta toxicity
por: Gorsky, Marianna Karina, et al.
Publicado: (2017)

Do cerebrospinal fluid transfer methods affect measured amyloid β42, total tau, and phosphorylated tau in clinical practice?
por: Paterson, Ross W., et al.
Publicado: (2015)

Osmotin attenuates amyloid beta-induced memory impairment, tau phosphorylation and neurodegeneration in the mouse hippocampus
por: Ali, Tahir, et al.
Publicado: (2015)

Communicating assemblies of biomimetic nanocapsules
por: Zhou, Hongda, et al.
Publicado: (2021)

Artificial Biomimetic Electrochemical Assemblies
por: Zidarič, Tanja, et al.
Publicado: (2022)

Anticoagulants inhibit proteolytic clearance of plasma amyloid beta
por: Yang, Lu, et al.
Publicado: (2017)

Rational integration of defense and repair synergy on PEEK osteoimplants via biomimetic peptide clicking strategy
por: Li, Meng, et al.
Publicado: (2021)

Reference intervals for plasma amyloid-β, total tau, and phosphorylated tau181 in healthy elderly Chinese individuals without cognitive impairment
por: Chen, Jingshan, et al.
Publicado: (2023)

Peripheral macrophages not ADept at amyloid clearance
por: Jay, Taylor, et al.
Publicado: (2015)

Tyramine and Amyloid Beta 42: A Toxic Synergy
por: Dhakal, Sudip, et al.
Publicado: (2020)

Different Synergy in Amyloids and Biologically Active Forms of Proteins
por: Fabian, Piotr, et al.
Publicado: (2019)

Biomimetic hydroxyapatite nanocrystals are an active carrier for Salmonella bacteriophages
por: Fulgione, Andrea, et al.
Publicado: (2019)

The Fate of Tau Aggregates Between Clearance and Transmission
por: Seitkazina, Assel, et al.
Publicado: (2022)

Different Amyloid-β Self-Assemblies Have Distinct Effects on Intracellular Tau Aggregation
por: Shin, Woo Shik, et al.
Publicado: (2019)

TTBK2: A Tau Protein Kinase beyond Tau Phosphorylation
por: Liao, Jung-Chi, et al.
Publicado: (2015)

Peripheral inflammation increases PKR activation, Tau phosphorylation and amyloid β production in wild-type mice
por: Mouton-Liger, François, et al.
Publicado: (2013)

Optimized Turmeric Extract Reduces β-Amyloid and Phosphorylated Tau Protein Burden in Alzheimer’s Transgenic Mice
por: Douglas Shytle, R, et al.
Publicado: (2012)

Mechanical Dilution of Beta-amyloid Peptide and Phosphorylated Tau Protein in Alzheimer's Disease: Too Simple to be True?
por: Menéndez González, Manuel
Publicado: (2017)

Plasma phosphorylated tau 181 predicts amyloid status and conversion to dementia stage dependent on renal function
por: Lehmann, Sylvain, et al.
Publicado: (2023)

Assembling strategy to synthesize palladium modified kaolin nanocomposites with different morphologies
por: Li, Xiaoyu, et al.
Publicado: (2015)

Standardization of Assay Procedures for Analysis of the CSF Biomarkers Amyloid β ((1-42)), Tau, and Phosphorylated Tau in Alzheimer's Disease: Report of an International Workshop
por: Teunissen, Charlotte E., et al.
Publicado: (2010)

Ventricular volume in relation to lumbar CSF levels of amyloid-β 1–42, tau and phosphorylated tau in iNPH, is there a dilution effect?
por: Lidén, Simon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_sasjccampdt3tfe6higfampt6h